{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T04:30:47Z","timestamp":1766377847782},"reference-count":42,"publisher":"Bentham Science Publishers Ltd.","issue":"13","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Malignant ascites is one of the severe complications of hepatocellular\ncarcinoma, which can be regarded as a unique tumor microenvironment of hepatocellular\ncarcinoma. The identification of novel biomarkers in malignant ascites could\nbe crucial to differentiate patients with hepatocellular carcinoma and cirrhotic ascites.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The study aimed to distinguish the metabolomics of malignant ascites in patients\nwith hepatocellular carcinoma from that of non-malignant ascites (cirrhotic\nascites).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Liquid chromatography-mass spectrometry was performed to analyze the differentially\ndistributed biomarkers in patients with malignant ascites and hepatocellular carcinoma\n(n = 39), as well as in patients with cirrhotic ascites, which were taken as controls\n(n = 36).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Our results suggest that the key factors associated with pathways, such as\narachidonic acid, phenylalanine, and glutamic acid pathways, are potential ascitic fluidbased\nbiomarkers for differentiating hepatocellular carcinoma with cirrhosis ascites; the\nresults also provide a clinical pathophysiological interpretation of biomarkers and\nmetabolic pathways relevant to disease status.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Our results suggest that the key factors associated with pathways, such as\narachidonic acid, phenylalanine, and glutamic acid pathways, are potential ascitic fluidbased\nbiomarkers for differentiating hepatocellular carcinoma with cirrhosis ascites; the\nresults also provide a clinical pathophysiological interpretation of biomarkers and\nmetabolic pathways relevant to disease status.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867330666230324153552","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T12:00:32Z","timestamp":1679659232000},"page":"1769-1780","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolome Profiling of Malignant Ascites Identifies Candidate\nMetabolic Biomarkers of Hepatocellular Carcinoma"],"prefix":"10.2174","volume":"31","author":[{"given":"Weijia","family":"Wang","sequence":"first","affiliation":[{"name":"Department of International Medical Services (IMS), Beijing Tiantan Hospital of Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of International Medical Services (IMS), Beijing Tiantan Hospital of Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinsheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Spleen and Gastroenterology, Henan Provincial Hospital\nof Traditional Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peilin","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of International Medical Services (IMS), Beijing Tiantan Hospital of Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41419-018-0399-y","volume":"9","author":"Zheng L.","year":"2018","unstructured":"Zheng L.; Xu M.; Xu J.; Wu K.; Fang Q.; Liang Y.; Zhou S.; Cen D.; Ji L.; Han W.; Cai X.; ELF3 promotes epithelial\u2013mesenchymal transition by protecting ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinoma. Cell Death Dis  2018,9(3),387","journal-title":"Cell Death Dis"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra1001683","volume":"365","author":"El-Serag H.B.","year":"2011","unstructured":"El-Serag H.B.; Hepatocellular carcinoma. N Engl J Med  2011,365(12),1118-1127","journal-title":"N Engl J Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"Pavlova N.N.","year":"2016","unstructured":"Pavlova N.N.; Thompson C.B.; The emerging hallmarks of cancer metabolism. Cell Metab  2016,23(1),27-47","journal-title":"Cell Metab"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10147-012-0396-6","volume":"18","author":"Cavazzoni E.","year":"2013","unstructured":"Cavazzoni E.; Bugiantella W.; Graziosi L.; Franceschini M.S.; Donini A.; Malignant ascites: Pathophysiology and treatment. Int J Clin Oncol  2013,18(1),1-9","journal-title":"Int J Clin Oncol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ijpharm.2015.08.073","volume":"503","author":"Watala C.","year":"2016","unstructured":"Watala C.; Karolczak K.; Kassassir H.; Talar M.; Przygodzki T.; Maczynska K.; Labieniec-Watala M.; How do the full-generation poly(amido)amine (PAMAM) dendrimers activate blood platelets? Activation of circulating platelets and formation of &#x201C;fibrinogen aggregates&#x201D; in the presence of polycations. Int J Pharm  2016,503(1-2),247-261","journal-title":"Int J Pharm"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/jocs.12255","volume":"29","author":"Pillai R.C.","year":"2014","unstructured":"Pillai R.C.; Fraser J.F.; Ziegenfuss M.; Bhaskar B.; Influence of circulating levels of fibrinogen and perioperative coagulation parameters on predicting postoperative blood loss in cardiac surgery: A prospective observational study. J Card Surg  2014,29(2),189-195","journal-title":"J Card Surg"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4254\/wjh.v5.i5.251","volume":"5","author":"Moore C.M.","year":"2013","unstructured":"Moore C.M.; Van Thiel D.H.; Cirrhotic ascites review: Pathophysiology, diagnosis and management. World J Hepatol  2013,5(5),251-263","journal-title":"World J Hepatol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-13-S16-S7","volume":"13","author":"Oberg A.L.","year":"2012","unstructured":"Oberg A.L.; Mahoney D.W.; Statistical methods for quantitative mass spectrometry proteomic experiments with labeling. BMC Bioinformatics  2012,13(S16),7","journal-title":"BMC Bioinformatics"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ymeth.2012.10.001","volume":"62","author":"Thompson J.W.","year":"2013","unstructured":"Thompson J.W.; Forrester M.T.; Moseley M.A.; Foster M.W.; Solid-phase capture for the detection and relative quantification of S-nitrosoproteins by mass spectrometry. Methods  2013,62(2),130-137","journal-title":"Methods"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.gene.2012.12.029","volume":"515","author":"Mehrotra S.","year":"2013","unstructured":"Mehrotra S.; Goyal V.; Evaluation of designer crops for biosafety-A scientist\u2019s perspective. Gene  2013,515(2),241-248","journal-title":"Gene"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cca.2016.10.006","volume":"463","author":"Sauzay C.","year":"2016","unstructured":"Sauzay C.; Petit A.; Bourgeois A.M.; Barbare J.C.; Chauffert B.; Galmiche A.; Houessinon A.; Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma. Clin Chim Acta  2016,463,39-44","journal-title":"Clin Chim Acta"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1111\/j.1742-4658.2007.05673.x","volume":"274","author":"Lindon J.C.","year":"2007","unstructured":"Lindon J.C.; Holmes E.; Nicholson J.K.; Metabonomics in pharmaceutical R and D. FEBS J  2007,274(5),1140-1151","journal-title":"FEBS J"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/5484976","volume":"2018","author":"Zhang J.","year":"2018","unstructured":"Zhang J.; Liang R.; Wei J.; Ye J.; He Q.; ChunlingYuan ; Ye J.; Li Y.; Liu Z.; Lin Y.; Identification of candidate biomarkers in malignant ascites from patients with hepatocellular carcinoma by iTRAQ-based quantitative proteomic analysis. BioMed Res Int  2018,2018,1-11","journal-title":"BioMed Res Int"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12876-016-0546-9","volume":"16","author":"Lee S.S.","year":"2016","unstructured":"Lee S.S.; Min H.J.; Choi J.Y.; Cho H.C.; Kim J.J.; Lee J.M.; Kim H.J.; Ha C.Y.; Kim H.J.; Kim T.H.; Kim J.H.; Lee O.J.; Usefulness of ascitic fluid lactoferrin levels in patients with liver cirrhosis. BMC Gastroenterol  2016,16(1),132","journal-title":"BMC Gastroenterol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jpba.2017.06.049","volume":"145","author":"Sui Z.","year":"2017","unstructured":"Sui Z.; Li Q.; Zhu L.; Wang Z.; Lv C.; Liu R.; Xu H.; He B.; Li Z.; Bi K.; An integrative investigation of the toxicity of Aconiti kusnezoffii radix and the attenuation effect of its processed drug using a UHPLC-Q-TOF based rat serum and urine metabolomics strategy. J Pharm Biomed Anal  2017,145,240-247","journal-title":"J Pharm Biomed Anal"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1002\/hep.26130","volume":"57","author":"Wang X.","year":"2013","unstructured":"Wang X.; Zhang A.; Sun H.; Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma. Hepatology  2013,57(5),2072-2077","journal-title":"Hepatology"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jep.2012.01.033","volume":"140","author":"Jiang M.","year":"2012","unstructured":"Jiang M.; Lu C.; Zhang C.; Yang J.; Tan Y.; Lu A.; Chan K.; Syndrome differentiation in modern research of traditional Chinese medicine. J Ethnopharmacol  2012,140(3),634-642","journal-title":"J Ethnopharmacol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1021\/pr100226m","volume":"9","author":"Zira A.N.","year":"2010","unstructured":"Zira A.N.; Theocharis S.E.; Mitropoulos D.; Migdalis V.; Mikros E.; (1)H NMR metabonomic analysis in renal cell carcinoma: A possible diagnostic tool. J Proteome Res  2010,9(8),4038-4044","journal-title":"J Proteome Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jchromb.2007.10.022","volume":"866","author":"Lu X.","year":"2008","unstructured":"Lu X.; Zhao X.; Bai C.; Zhao C.; Lu G.; Xu G.; LC\u2013MS-based metabonomics analysis. J Chromatogr B Analyt Technol Biomed Life Sci  2008,866(1-2),64-76","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1021\/pr1007703","volume":"9","author":"Jiang W.","year":"2010","unstructured":"Jiang W.; Qiu Y.; Ni Y.; Su M.; Jia W.; Du X.; An automated data analysis pipeline for GC-TOF-MS metabonomics studies. J Proteome Res  2010,9(11),5974-5981","journal-title":"J Proteome Res"},{"key":"ref=21","first-page":"158","volume":"9","author":"Safaei A.","year":"2016","unstructured":"Safaei A.; Arefi Oskouie A.; Mohebbi S.R.; Rezaei-Tavirani M.; Mahboubi M.; Peyvandi M.; Okhovatian F.; Zamanian-Azodi M.; Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases. Gastroenterol Hepatol Bed Bench  2016,9(3),158-173","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"153943","DOI":"10.1016\/j.phymed.2022.153943","volume":"98","author":"Cui W.","year":"2022","unstructured":"Cui W.; Zhang J.; Wu D.; Zhang J.; Zhou H.; Rong Y.; Liu F.; Wei B.; Xu X.; Ponicidin suppresses pancreatic cancer growth by inducing ferroptosis: Insight gained by mass spectrometry-based metabolomics. Phytomedicine  2022,98,153943","journal-title":"Phytomedicine"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"115258","DOI":"10.1016\/j.bcp.2022.115258","volume":"205","author":"Zhang H.","year":"2022","unstructured":"Zhang H.; Bian S.; Xu Z.; Gao M.; Wang H.; Zhang J.; Zhang M.; Ke Y.; Wang W.; Chen Z.S.; Xu H.; The effect and mechanistic study of encequidar on reversing the resistance of SW620\/AD300 cells to doxorubicin. Biochem Pharmacol  2022,205,115258","journal-title":"Biochem Pharmacol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S0377-1237(11)60100-7","volume":"67","author":"Jha V.K.","year":"2011","unstructured":"Jha V.K.; Shenoy G.; Borpujari P.J.; Banerjee M.; Biomarkers of malignant ascites-a myth or reality. Med J Armed Forces India  2011,67(4),398","journal-title":"Med J Armed Forces India"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.cmet.2016.03.016","volume":"23","author":"Coloff J.L.","year":"2016","unstructured":"Coloff J.L.; Murphy J.P.; Braun C.R.; Harris I.S.; Shelton L.M.; Kami K.; Gygi S.P.; Selfors L.M.; Brugge J.S.; Differential glutamate metabolism in proliferating and quiescent mammary epithelial cells. Cell Metab  2016,23(5),867-880","journal-title":"Cell Metab"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1158\/1078-0432.CCR-11-1217","volume":"18","author":"Prickett T.D.","year":"2012","unstructured":"Prickett T.D.; Samuels Y.; Molecular pathways: Dysregulated glutamatergic signaling pathways in cancer. Clin Cancer Res  2012,18(16),4240-4246","journal-title":"Clin Cancer Res"},{"key":"ref=27","first-page":"59","volume":"1","author":"Matsuda K.","year":"2012","unstructured":"Matsuda K.; Novel susceptibility loci for hepatocellular carcinoma in chronic HBV carriers. Hepatobiliary Surg Nutr  2012,1(1),59-60","journal-title":"Hepatobiliary Surg Nutr"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"6714","DOI":"10.1158\/1078-0432.CCR-12-1099","volume":"18","author":"Nahon P.","year":"2012","unstructured":"Nahon P.; Amathieu R.; Triba M.N.; Bouchemal N.; Nault J.C.; Ziol M.; Seror O.; Dhonneur G.; Trinchet J.C.; Beaugrand M.; Le Moyec L.; Identification of serum proton NMR metabolomic fingerprints associated with hepatocellular carcinoma in patients with alcoholic cirrhosis. Clin Cancer Res  2012,18(24),6714-6722","journal-title":"Clin Cancer Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1007\/s00216-018-0883-3","volume":"410","author":"Han M.","year":"2018","unstructured":"Han M.; Xie M.; Han J.; Yuan D.; Yang T.; Xie Y.; Development and validation of a rapid, selective, and sensitive LC\u2013MS\/MS method for simultaneous determination of d- and l-amino acids in human serum: application to the study of hepatocellular carcinoma. Anal Bioanal Chem  2018,410(10),2517-2531","journal-title":"Anal Bioanal Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41568-018-0054-z","volume":"18","author":"Keshet R.","year":"2018","unstructured":"Keshet R.; Szlosarek P.; Carracedo A.; Erez A.; Rewiring urea cycle metabolism in cancer to support anabolism. Nat Rev Cancer  2018,18(10),634-645","journal-title":"Nat Rev Cancer"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.3390\/cancers11101497","volume":"11","author":"Kim D.","year":"2019","unstructured":"Kim D.; Cho E.; Yu K.S.; Jang I.J.; Yoon J.H.; Park T.; Cho J.Y.; Comprehensive metabolomic search for biomarkers to differentiate early stage hepatocellular carcinoma from cirrhosis. Cancers  2019,11(10),1497","journal-title":"Cancers"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1126\/science.aam9305","volume":"358","author":"Spinelli J.B.","year":"2017","unstructured":"Spinelli J.B.; Yoon H.; Ringel A.E.; Jeanfavre S.; Clish C.B.; Haigis M.C.; Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass. Science  2017,358(6365),941-946","journal-title":"Science"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"857S","DOI":"10.3945\/ajcn.2009.27462Z","volume":"90","author":"Brosnan M.E.","year":"2009","unstructured":"Brosnan M.E.; Brosnan J.T.; Hepatic glutamate metabolism: A tale of 2 hepatocytes. Am J Clin Nutr  2009,90(3),857S-861S","journal-title":"Am J Clin Nutr"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1471-4914(02)02437-1","volume":"8","author":"Mian A.","year":"2002","unstructured":"Mian A.; Lee B.; Urea-cycle disorders as a paradigm for inborn errors of hepatocyte metabolism. Trends Mol Med  2002,8(12),583-589","journal-title":"Trends Mol Med"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"63890","DOI":"10.18632\/oncotarget.19173","volume":"8","author":"Gong Z.G.","year":"2017","unstructured":"Gong Z.G.; Zhao W.; Zhang J.; Wu X.; Hu J.; Yin G.C.; Xu Y.J.; Metabolomics and eicosanoid analysis identified serum biomarkers for distinguishing hepatocellular carcinoma from hepatitis B virus-related cirrhosis. Oncotarget  2017,8(38),63890-63900","journal-title":"Oncotarget"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"e101964","DOI":"10.15252\/embj.2019101964","volume":"38","author":"Yang F.","year":"2019","unstructured":"Yang F.; Li J.; Deng H.; Wang Y.; Lei C.; Wang Q.; Xiang J.; Liang L.; Xia J.; Pan X.; Li X.; Long Q.; Chang L.; Xu P.; Huang A.; Wang K.; Tang N.;  1-1 deficiency activates  2\/  1R Axis in   via accumulation of oncometabolite succinylacetone. EMBO J  2019,38(15),e101964","journal-title":"EMBO J"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1093\/jnci\/djq290","volume":"102","author":"Linkous A.G.","year":"2010","unstructured":"Linkous A.G.; Yazlovitskaya E.M.; Hallahan D.E.; Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis. J Natl Cancer Inst  2010,102(18),1398-1412","journal-title":"J Natl Cancer Inst"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1158\/1940-6207.CAPR-17-0249","volume":"11","author":"Jee S.H.","year":"2018","unstructured":"Jee S.H.; Kim M.; Kim M.; Yoo H.J.; Kim H.; Jung K.J.; Hong S.; Lee J.H.; Metabolomics profiles of hepatocellular carcinoma in a Korean prospective cohort: The Korean cancer prevention study-II. Cancer Prev Res (Phila)  2018,11(5),303-312","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.3748\/wjg.v9.i11.2592","volume":"9","author":"Sun X.M.","year":"2003","unstructured":"Sun X.M.; Dong W.G.; Yu B.P.; Luo H.S.; Yu J.P.; Detection of type IV collagenase activity in malignant ascites. World J Gastroenterol  2003,9(11),2592-2595","journal-title":"World J Gastroenterol"},{"key":"ref=40","first-page":"2441","volume":"13","author":"Kountouras J.","year":"1993","unstructured":"Kountouras J.; Boura P.; Tsapas G.; Charisis K.; Magoula I.; Tsakiri I.; Value of ascitic fluid ferritin in the differential diagnosis of malignant ascites. Anticancer Res  1993,13(6B),2441-2445","journal-title":"Anticancer Res"},{"key":"ref=41","first-page":"642","volume":"7","author":"Wang X.","year":"1999","unstructured":"Wang X.; Lin G.; Huang Y.; Study on biomarkers of serum and ascites in patients with liver cirrhosis or liver cancer. World Chin Digestion J  1999,7,642-643","journal-title":"World Chin Digestion J"},{"key":"ref=42","first-page":"91","volume":"16","author":"Xu P.","year":"1990","unstructured":"Xu P.; Zhu B.; Clinical significance of serum and ascites &#x3B1;-L-fucosylase in liver cancer. Jiangsu Med  1990,16(2),91-92","journal-title":"Jiangsu Med"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867330666230324153552","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/214960\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867330666230324153552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T17:09:35Z","timestamp":1713373775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/214960\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":42,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867330666230324153552","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-05-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}